Recent Quotes (30 days)

You have no recent quotes
chg | %

Tandem Diabetes Care Inc  

(Public, NASDAQ:TNDM)   Watch this stock  
Find more results for TNDM
+0.18 (4.66%)
Mar. 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.84 - 4.14
52 week 2.14 - 21.00
Open 3.90
Vol / Avg. 1.76M/1.62M
Mkt cap 40.88M
P/E     -
Div/yield     -
EPS -21.68
Shares 44.70M
Beta 0.20
Inst. own 12%
May 16, 2018
Tandem Diabetes Care Inc Annual Shareholders Meeting (Estimated) - 6:00p.m. EDT - Add to calendar
Apr. 25, 2018
Q1 2018 Tandem Diabetes Care Inc Earnings Release (Estimated) - 4:00p.m. EDT - Add to calendar
Mar. 21, 2018
Tandem Diabetes Care Inc at Oppenheimer Healthcare Conference - 11:30a.m. EDT - Add to calendar
Mar. 14, 2018
Tandem Diabetes Care Inc at Cowen Health care Conference
Mar. 1, 2018
Q4 2017 Tandem Diabetes Care Inc Earnings Call - Webcast
Mar. 1, 2018
Q4 2017 Tandem Diabetes Care Inc Earnings Release
Jan. 9, 2018
Preliminary Q4 2017 Tandem Diabetes Care Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec. '17) 2017
Net profit margin -156.36% -115.83%
Operating margin -23.78% -58.50%
EBITD margin - -52.12%
Return on average assets -275.71% -119.99%
Return on average equity - -
Employees 574 -
CDP Score - -


11075 Roselle St
SAN DIEGO, CA 92121-1204
United States - Map
+1-858-3666900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Officers and directors

Dick P. Allen Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Kim D. Blickenstaff President, Chief Executive Officer, Director
Age: 64
Bio & Compensation  - Reuters
Leigh Vosseller Chief Financial Officer, Senior Vice President
Bio & Compensation  - Reuters
John F. Sheridan Chief Operating Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
David B. Berger Esq. Executive Vice President, General Counsel, Secretary
Age: 47
Bio & Compensation  - Reuters
Brian B. Hansen Chief Commercial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Susan M. Morrison Chief Administrative Officer
Age: 37
Bio & Compensation  - Reuters
Edward L. Cahill Independent Director
Age: 61
Bio & Compensation  - Reuters
Fred E. Cohen Ph.D. M.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Howard E. Greene Jr. Independent Director
Age: 74
Bio & Compensation  - Reuters